Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

1.67
Delayed Data
As of Jun 22
 +0.06 / +3.73%
Today’s Change
1.50
Today|||52-Week Range
3.53
-34.51%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Sherman Michael A
President, Chief Executive & Financial Officer
Buy5/31/201744,285$2.10$93.0K-34.51%
Leamon Christopher P
Vice President-Research
Sale12/30/201623,244$2.55$59.3K-34.51%
Leamon Christopher P
Vice President-Research
Buy12/30/201626,178$2.10$55.0K-34.51%
Ellis P Ron
Sale6/24/201613,528$3.68$49.8K-49.24%
Low Philip S
Chief Scientific Officer
Buy11/15/201615,706$2.10$33.0K-43.20%
Brauer Keith E
Director
Buy7/27/201610,471$1.91$20.0K-47.81%
Sherman Michael A
President, Chief Executive & Financial Officer
Sale2/04/20173,092$2.18$6.7K-23.39%
Low Philip S
Chief Scientific Officer
Sale2/04/20171,888$2.18$4.1K-23.39%
Leamon Christopher P
Vice President-Research
Sale2/04/20171,888$2.18$4.1K-23.39%
Brinkley Michael A
Vice President-Quality
Sale2/04/20171,079$2.18$2.4K-23.39%
Page of 4